# Clinical Trials | Medications (@clinical_trials): Telegram channel statistics

Clinical Trials | Medications (@clinical_trials) on Telegram: 1,025 subscribers, +21 in 30 days. Daily subscriber chart, post reach, engagement rate and similar channels.

- Telegram: https://t.me/clinical_trials
- Category: [Health](https://telegraminformer.com/c/health.md)
- Language: English
- Audience country: International (no single country)
- Data as of: November 12, 2026
- Web page: https://telegraminformer.com/channels/clinical_trials

Description:

> Clinical Trials / Medications

## Key numbers

| Metric | Value |
|---|---|
| Subscribers | 1,025 |
| Change, 24 hours | 0 |
| Change, 7 days | – |
| Change, 30 days | +21 (2.1%) |
| Average post reach (views after 24 hours) | 19 |
| ERR (reach ÷ subscribers) | 1.9% |
| Interaction rate, ER (reactions ÷ views, 30 days) | 0% |
| Reactions per post (30 days) | 0 |
| Reposts per post (30 days) | not collected |
| Comments per post (30 days) | not collected |
| Posts per day (30 days) | 4.3 |
| Citation index (30 days) | – |
| Posts marked as ads (30 days) | 0 of 40 (0%) |

## Rankings by subscribers

- [#393 in Health](https://telegraminformer.com/c/health.md?page=8)
- [#5,682 among international channels](https://telegraminformer.com/catalog/international.md?page=114)
- [#7,925 among English channels](https://telegraminformer.com/channels.md?language=en&page=159)
- [#8,986 worldwide](https://telegraminformer.com/channels.md?page=180)

## Daily numbers, last 30 days

| Date | Subscribers | Change | Posts | Avg. views per post |
|---|---:|---:|---:|---:|
| 2026-11-12 | 1,025 | 0 | 3 | 11 |
| 2026-11-11 | 1,025 | +1 | 7 | 15 |
| 2026-11-10 | 1,024 | +1 | 5 | 23 |
| 2026-11-09 | 1,023 | +1 | 5 | 28 |
| 2026-11-06 | 1,022 | +18 | 4 | 31 |
| 2026-10-07 | 1,004 | – | 0 | – |

## Views as a post ages (posts of the last 30 days)

| Post age | Average views |
|---|---:|
| 1 h | 8 |
| 3 h | 8 |
| 6 h | 8 |
| 12 h | 13 |
| 24 h | 19 |
| 48 h | 25 |
| 3 days | 28 |
| 7 days | 29 |

## Recent posts

### 12 Nov 2026, 17:01 UTC · 8 views

> Blood thinner could offer a new way to treat osteoarthritis
> Osteoarthritis is the most common form of joint disease, a condition that causes joints to become painful and stiff. It can happen to any joint when the cartilage cushioning the ends of bones breaks down or wears away. Currently, there are no approved drugs to slow or stop the underlying disease. But there is a promising development from...

[Open post](https://t.me/clinical_trials/3329)

### 12 Nov 2026, 16:25 UTC · 11 views

> Five lifespan-extending treatments boost the same antioxidant in mice
> Aging is about far more than wrinkles and gray hair, despite what social media and advertisements might have us believe. The real concern lies beneath the surface, where the biology of aging is intertwined with a host of diseases, from heart disease to neurodegenerative diseases like Alzheimer's and Parkinson's to metabolic dis...

[Open post](https://t.me/clinical_trials/3328)

### 12 Nov 2026, 13:43 UTC · 16 views

> Papua New Guinean tree offers new lead in search for motor neuron disease treatments
> The natural world has long been one of medicine's most valuable resources, with countless therapies originating in plants, fungi or algae. So, when University of Wollongong (UOW) researchers went searching for a new treatment for motor neuron disease (MND), they turned to nature.
> https://medicalxpress.com/news/2...

[Open post](https://t.me/clinical_trials/3327)

### 11 Nov 2026, 20:23 UTC · 20 views

> More than a warning sign: Common cardiovascular biomarker may contribute to disease
> Heart disease is the leading cause of death in the United States, claiming a life nearly every 34 seconds. A major driver of these fatalities is heart failure, a progressive condition where the heart struggles to pump enough blood throughout the body.
> https://medicalxpress.com/news/2026-11-common-cardiovascular-b...

[Open post](https://t.me/clinical_trials/3326)

### 11 Nov 2026, 20:02 UTC · 15 views

> One day in the ICU without care from a pharmacist increases risk of death by 20%
> Patients in intensive care units who don't receive care from a pharmacist for even one day of their stay are 20% more likely to die, according to new research led by the University of Georgia. The work is published in the journal CHEST.
> https://medicalxpress.com/news/2026-11-day-icu-pharmacist-death.html

[Open post](https://t.me/clinical_trials/3325)

## Most viewed posts, last 30 days

- 3 Nov 2026, 17:45 UTC · 39 views: Fatty acid metabolism may help eliminate damaged and senescent cells Researchers have identified a mechanism involving fatty acid metabolis... [Open post](https://t.me/clinical_trials/3293)
- 5 Nov 2026, 14:40 UTC · 39 views: Stronger cholesterol treatment shrinks more plaque in heart arteries, new clinical trial finds Atherosclerosis is a condition in which chol... [Open post](https://t.me/clinical_trials/3302)
- 8 Nov 2026, 16:31 UTC · 37 views: Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials For people with painful knee osteoarthritis (OA) who... [Open post](https://t.me/clinical_trials/3309)
- 5 Nov 2026, 16:03 UTC · 36 views: Scientists use AI to develop bird flu vaccine that outperforms current stockpiled shot A University of Cambridge team has had a third succe... [Open post](https://t.me/clinical_trials/3303)
- 7 Nov 2026, 14:44 UTC · 35 views: Heart researchers unpack neutral findings from ZEUS, an anti-inflammatory clinical trial Like cholesterol, inflammation causally contribute... [Open post](https://t.me/clinical_trials/3308)

## Similar channels

- [Barbara O'Neill (@barbaraoneill_official)](https://telegraminformer.com/channels/barbaraoneill_official.md): 109,535 subscribers
- [MedBeds Technology (@medbedstechnologynews)](https://telegraminformer.com/channels/medbedstechnologynews.md): 90,355 subscribers
- [Dr. Tenpenny (@drtenpenny)](https://telegraminformer.com/channels/drtenpenny.md): 87,420 subscribers
- [The Universal Antidote Videos (@theuniversalantidote)](https://telegraminformer.com/channels/theuniversalantidote.md): 85,227 subscribers
- [Dr. Simone Gold (@drsimonegold)](https://telegraminformer.com/channels/drsimonegold.md): 78,785 subscribers
- [PrepLadder Medical (@medicalprep)](https://telegraminformer.com/channels/medicalprep.md): 75,933 subscribers
- [World Doctors Alliance (@worlddoctorsalliance)](https://telegraminformer.com/channels/worlddoctorsalliance.md): 74,691 subscribers
- [MBBS Materials by Dr MediRobot (@mbbsmaterials)](https://telegraminformer.com/channels/mbbsmaterials.md): 66,553 subscribers

## Questions

### How many subscribers does Clinical Trials | Medications have?

Clinical Trials | Medications (@clinical_trials) has 1,025 subscribers as of November 12, 2026.

### Is Clinical Trials | Medications growing?

Yes. It gained 21 subscribers in the last 30 days (2.1%).

### How many people see a post on Clinical Trials | Medications?

A typical post gets about 19 views within 24 hours, roughly 2% of its subscribers (the ERR).

### What is Clinical Trials | Medications about?

It is listed in Health, and posts mostly in English. The channel describes itself as: “Clinical Trials / Medications”

### Where does Clinical Trials | Medications rank?

By subscribers it is #393 in Health, #5,682 among international channels, #7,925 among English channels, #8,986 worldwide.

### Does Clinical Trials | Medications post ads?

None of its 40 posts in the last 30 days carried an ad label such as #ad or Sponsored. Unlabelled promotions can’t be detected.

## About this data

TelegramInformer collects these figures itself from public Telegram channels every day (subscriber counts, post views, reactions, forwards and mentions). Nothing is self-reported by channel owners. Ranks count only channels in our catalog.

Cite as: “Clinical Trials | Medications (@clinical_trials) Telegram statistics”, TelegramInformer, November 12, 2026, https://telegraminformer.com/channels/clinical_trials